On 12 January 2025, the European healthcare landscape will reach a pivotal milestone with the application of the EU Health Technology Assessment (HTA) Regulation.
https://www.eurordis.org/what-happens-hta-2025/
On 12 January 2025, the EU Health Technology Assessment (HTA) Regulation will begin to apply, marking a transformative moment in how health technologies and medicines are assessed across Europe.
This new regulatory framework is designed to enhance collaboration, efficiency, and inclusivity, with promising implications for the rare disease community. By streamlining processes, the Regulation could help accelerate access to essential treatments across EU Member States. But what exactly will change, and how will it impact patients, healthcare professionals, industry, and policymakers?
No hay comentarios:
Publicar un comentario